The U.S. contrast injector systems market size was valued at $330.23 Million in 2022 and is projected to reach $693.70 Million by 2032, registering a CAGR of 7.7% from 2023 to 2032.
Contrast injector system is a medical device that improves the quality of medical imaging by introducing contrast media into the patient’s body. Contrast media are substances that enhance the way X-rays, MRI, or CT scan images are captured and interpreted by the radiologist. These media have different chemical properties and are administered depending on the type of imaging modality used. In addition, the contrast injector system delivers the contrast media to the patient's body through an injection or infusion, with controlled flow rates and volumes. This allows for precise administration of the contrast media and ensures that the optimal amount of contrast is present in the area being imaged.
“The COVID-19 pandemic had a negative effect on the U.S. contrast injector systems market. Some governments mandated the closure of imaging facilities to reduce the spread of viral infection, while others were instructed to stop performing elective surgical procedures and medical examinations to slow the spread of disease. This reduced the demand for contrast injector systems in the healthcare system and hence negatively impacted the market.”
Market dynamics
The growth of the contrast injector systems market is attributed to various factors, including surge in demand for contrast injector systems in imaging procedures, rise in geriatric population, increase in chronic diseases, and rise in awareness & adoption of syringeless power injectors. The use of contrast injector systems in medical imaging procedures has indeed become more widespread in recent years due to the need for enhanced image quality, which is crucial for accurate diagnosis and treatment planning. Contrast media injected through these systems can highlight specific tissues or structures, making them more visible on imaging scans. Such advantages offered by the U.S. contrast injector systems market leads to surge in demand for contrast injector systems.
In addition, factors contributing to the increased demand for contrast injector systems are the growing need for medical imaging and the rising geriatric population in the U.S. As the prevalence of chronic diseases and conditions such as cancer and cardiovascular disease continue to rise, the demand for medical imaging procedures is increasing. For instance, the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) states that by 2040, the number of older adults is expected to reach 80.8 million. It further stated that aging increases the risk of chronic diseases such as heart disease, diabetes, arthritis, and cancer. Thus, this increases the demand for effective diagnosis procedures including the contrast injector systems, which boosts the growth of the market.
Furthermore, the adoption of minimally invasive procedures is driving the demand for contrast injector systems. These systems allow precise delivery of contrast media through small incisions or catheters, reducing the need for more invasive procedures. Moreover, patient safety is another crucial factor that is driving the use of contrast injector systems in medical imaging procedures. These systems can help reduce the amount of contrast media needed for imaging, which can reduce the risk of adverse reactions and side effects.
However, factors such as the high cost of contrast injector systems and risk associated with contrast injector systems and contrast media restrain the growth of the market. The major challenge faced by the U.S. contrast injector systems market is the high cost of advanced systems, which often have limited insurance coverage. The significant financial burden of these systems can be especially challenging for healthcare facilities with limited resources, such as smaller or rural facilities. This can lead to a reluctance to invest in new equipment or upgrade existing systems, which may hinder market growth and limit the adoption of contrast injector systems.
In addition, repeated use of contrast injector systems in medical imaging procedures may potentially have adverse effects on patients. While contrast agents used in imaging procedures are considered safe, there is a risk of allergic reactions, nephrotoxicity, and other adverse events associated with their use. The risk of adverse effects may increase with multiple uses of contrast agents and imaging procedures.
On the contrary, the contrast injector systems market has witnessed significant technological advancements, which are anticipated to contribute to the market growth during the forecast period. These systems are increasingly used in medical imaging to enhance the visibility of blood vessels, organs, and other structures. Dual-head injectors, which allow contrast media to be injected at different rates and volumes, are among the latest advancements in contrast injector systems. This provides greater flexibility in imaging protocols. In addition, the advanced imaging and monitoring capabilities of these systems enable real-time visualization and control of contrast media injection, making medical imaging procedures more accurate and efficient. This is anticipated to contribute to the growth of the market in the near future.
The outbreak of COVID-19 had a negative impact on the growth of U.S. contrast injector systems market. Governments in various regions led to the closure of imaging facilities to mitigate the spread of the virus and reduce the risk of injury. Moreover, many healthcare facilities were instructed to suspend elective surgical procedures and medical examinations to control the pandemic's spread, which resulted in patients having to wait for essential imaging procedures. In addition, radiology centers experienced a significant reduction in the number of imaging cases in 2020.
In addition, the COVID-19 pandemic led to a shortage of intravenous contrast media products for CT imaging, as some production facilities were temporarily shut down due to the pandemic's impact. This shortage negatively affected hospitals and health systems, leading to a decrease in consumables for imaging and, consequently, a negative impact on the market.
However, as the situation improves and the demand for imaging procedures increases post-pandemic, the demand for contrast injectors is likely to increase. This will create opportunities for manufacturers to invest in expanding their production capacity to meet the growing demand for these products. Therefore, although the pandemic had a negative impact on the market, there is scope for growth in the future.
Segmental Overview
The U.S. contrast injector systems market is segmented on the basis of product type, application, and end user. On the basis of product type, the market is categorized into injectors systems, consumables, and accessories. By application, it is segregated into interventional radiology, interventional cardiology, and radiology. Depending on end user, it is fragmented into diagnostic centers, clinics, hospitals, and others.
By Product Type:
On the basis of product type, the consumables segment dominated the market in terms of revenue in 2022 and is anticipated to maintain its dominance throughout the forecast period. This growth is attributed to surge in demand for consumables such as syringes, needles, tubing, and other disposable components that are necessary for the operation of the injector system.
By Product Type
Consumables segment held a dominant position in 2022 and continued to maintain the lead from 2023 to 2032. Whereas the Injector Systems segment is anticipated to grow at a fastest rate during the forecast period.
In addition, the dominance of the consumables segment is attributed to factors such as high demand for these disposable items in medical facilities, increase in prevalence of medical imaging procedures, and need for safe and sterile disposable components in healthcare settings.
On the other hand, the injectors systems segment is anticipated to be the fastest growing segment during the forecast period owing to increase in demand for medical imaging procedures, advancements in imaging technologies, and need for more efficient and precise contrast delivery during procedures. In addition, the development of new and innovative injector systems with improved features, such as automation and enhanced imaging capabilities, drives the growth of injector systems segment.
By Application:
On the basis of application, the radiology segment dominated the market in 2021, and is anticipated to continue this trend during the forecast period. The growth of the segment is attributed to increase in number of radiology procedures in U.S., high demand for accurate and efficient imaging technologies, and need for advanced contrast injector systems in radiology applications.
By Application
Radiology segment held a dominant position in the market in 2022 and the interventional Radiology segment is anticipated to grow at a fastest rate during the forecast period.
In addition, the demand for contrast injector systems in radiology is increasing due to rise in number of diagnostic imaging procedures that require the use of contrast agents. Moreover, increase in prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders is driving the demand for advanced imaging technologies, including contrast injector systems, in radiology.
On the other hand, the interventional radiology segment is anticipated to grow at a fastest rate during the forecast period due to rise in preference for interventional radiology using contrast injector systems. In addition, key players are developing efficient products that have applications in interventional radiology and this leads to rise in adoption of contrast injector systems for disease diagnosis.
By End User:
On the basis of end user, the hospitals segment dominated the market in terms of revenue in 2022. This growth is attributed to rise in imaging procedures in hospitals such as CT, and MRI and subsequent rise in contrast injector systems.
In addition, the onset of complex diseases among the population base has necessitated the need for detailed examination and early diagnosis pattern of diseases, in turn, increasing the installation for contrast injector systems in hospitals. This has further led to rise in the number of procedures performed using contrast injecting systems in the hospitals, thus supplementing the growth of segment.
On the other hand, the diagnostic center segment is anticipated to grow at a fastest rate during the forecast period. This is due to the change in preference of people or shift of people toward diagnostic centers for diagnosis of complex diseases. Furthermore, the installation of advanced contrast injector systems in diagnostic centers help improve the accuracy and efficiency of medical imaging procedures. With the use of these systems, healthcare professionals can deliver contrast agents more accurately and efficiently, which may lead to better diagnoses and treatment outcomes for patients suffering from complex diseases.
Competition Analysis
Competitive analysis and profiles of the major players in the contrast injector systems market such as AngioDynamics, Inc., Bayer AG, Bracco, Guerbet, Lepu Medical Technology (Beijing) Co., Ltd., Medtronic plc, Merit Medical Systems, Inc., Nemoto Kyorindo Co., Ltd. and SOMA TECH INTL, and Ulrich GmbH & Co. KG are provided in this report. Major players have adopted partnership and acquisition as key developmental strategies to improve the product portfolio of the U.S. contrast injector systems market.
Agreements in the contrast injector systems market
In November 2022, Ulrich GmbH & Co. KG and GE Healthcare, a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator signed an agreement to distribute a GE Healthcare branded CT motion injector manufactured by Ulrich medical in the U.S.
Partnership in the contrast injector systems market
In December 2021, Ulrich GmbH & Co. KG announced that they enter into a strategic partnership with Qaelum NV to combine their advanced contrast management solution with the contrast media injectors of Ulrich medical to support the needs of hospitals and imaging networks
U.S. Contrast Injector Systems Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By Application |
|
 By End User |
|
Analyst Review
This section provides various opinions of the top-level CXOs in the U.S. contrast injector systems industry. In accordance with the study conducted, contrast injector systems are expected to gain high traction in the near future, owing to an increase in diagnosis of chronic diseases such as cancer and cardiac diseases. In addition, contrast injector systems are gaining ground among healthcare providers, as they offer benefits for the diagnosis and treatment of clinical disorders.
The CXOs further added that technological advancements in contrast injector systems lead to the provision of advanced treatment options for the management of chronic disease patients. The demand for contrast injector systems is on a continuous rise, due to surge in geriatric population prone to chronic diseases and increase in number of diagnostic procedures in the U.S. However, high cost of the injector systems and certain side effects of the contrast media hamper the market growth to some extent.
Moreover, minimally invasive procedures are becoming increasingly popular as a viable alternative to traditional surgical procedures. These procedures require the use of contrast media for enhanced image quality, which, in turn, drives the demand for contrast injector systems.
Furthermore, healthcare expenditure in the U.S has been increasing in recent years, which has led to an increase in the number of medical imaging procedures performed. This increase in demand for medical imaging procedures is driving the demand for contrast injector systems.
The total market value of U.S. contrast injector systems marketis $330.23 million in 2022.
The forecast period for U.S. contrast injector systems marketis 2023-2032.
The market value of U.S. contrast injector systems market in 2032 is $6,93.70 million.
The base year is 2022 in U.S. contrast injector systems market
Top companies such as AngioDynamics, Inc., Bayer AG, Bracco, Guerbet, Lepu Medical Technology (Beijing) Co., Ltd., Medtronic plc, Merit Medical Systems, Inc., Nemoto Kyorindo Co., Ltd., SOMA TECH INTL and Ulrich GmbH & Co. KG, held a high market position in 2022.
The consumables segment is the most influencing segment in the U.S. contrast injector systems market,owing to the surge in demand for high quality consumables and rise in diagnositc imaging processes.
Surge in demand for contrast injector systems in imaging procedures, rise in geriatric population and increase in chronic diseases and increase in awareness and adoption of syringeless power injectorsare the key factors that drove the growth of U.S. contrast injector systems market.
Asia-Pacific region was the largest revenue contributor to the U.S. contrast injector systems market and also grew at a fastest rate during the forecast period with a CAGR of 7.7%.
Loading Table Of Content...
